News & Analysis - CNBC

1. Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production

2. Super Micro surges 15% on new order and margin disclosure after SpaceX announcement

3. Nike to cut off thousands of online distributors in China, restructure digital footprint

4. Goldman Sachs creates private markets platform as rich investors seek the next SpaceX and Stripe

5. These Japanese AI winners don’t make chips. They make toilets, glass fiber and seasoning

6. OpenAI appoints two new members to board of directors

7. The Fed rang the alarm about Anthropic's Mythos AI model — but had to go months without it

8. Capital One earnings were good enough but didn't answer the big question hanging over the stock

9. Jamie Dimon says markets underestimate risks and he wouldn't buy stocks or Treasurys at current prices

10. GM announces new gas-powered Cadillac vehicles amid EV pullback

11. The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame

12. Apple prepares a new way to buy iPhones. Plus, making sense of Google's new AI models

13. Sony’s 'ironic' PlayStation disc decision upends gamer conventions and threatens a $7 billion resale market

14. Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

15. IRS chief Frank Bisignano dismisses JPMorgan spying allegations

16. Japan exports and imports grow at fastest pace in June since November 2022, beating estimates

17. Prediction markets and their opponents are spending more to influence Congress in 2026

18. RFK Jr. says cyclospora outbreak is 'under control'

19. Mamdani says New York lacks authority to arrest Netanyahu, calls him ‘war criminal’

20. Bets against SpaceX grow to 32% of float as Elon Musk warns short sellers won't survive